Risk Profile in Chronic Kidney Disease Stage 3: Older versus Younger Patients

被引:21
作者
McIntyre, Natasha J. [1 ]
Fluck, Richard J. [1 ]
McIntyre, Christopher W. [1 ,2 ]
Taal, Maarten W. [1 ]
机构
[1] Royal Derby Hosp, Dept Renal Med, Derby DE22 3NE, England
[2] Univ Nottingham, Dept Vasc Med, Nottingham NG7 2RD, England
来源
NEPHRON CLINICAL PRACTICE | 2011年 / 119卷 / 04期
关键词
Cardiovascular disease; Chronic kidney disease; Epidemiology; Older patients; Risk factors; GLOMERULAR-FILTRATION-RATE; PULSE-WAVE VELOCITY; RENAL-DISEASE; CARDIOVASCULAR EVENTS; ARTERIAL STIFFNESS; URIC-ACID; ALL-CAUSE; MORTALITY; METAANALYSIS; PREVALENCE;
D O I
10.1159/000329109
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The prevalence of chronic kidney disease (CKD) increases with age, but its significance in older patients is uncertain and is regarded by some as part of 'normal aging'. Moreover, subjects >= 75 years are often excluded from research studies. We therefore undertook a prospective study of patients with CKD stage 3 in primary care to compare the risk profile of older versus younger subjects. Methods: Subjects with an estimated glomerular filtration rate (eGFR) 59-30 ml/min/1.73 m(2) on two measurements were recruited from 32 primary care practices. Medical history and demographic data were obtained and participants underwent clinical assessment as well as urine and serum biochemistry tests. Results: 1,741 participants were recruited: mean age 72.9 +/- 8 9 years; 60% female; 98% white; 17% diabetic. Mean eGFR was 52.5 +/- 8 10 ml/min/1.73 m(2) and 16.9% had albuminuria. Subjects >= 75 years had a significantly lower eGFR than younger subjects and a higher risk profile characterised by greater albuminuria, more arterial stiffness and higher serum uric acid levels. Conclusion: Older subjects with CKD stage 3 evidenced a higher risk profile for CKD progression and cardiovascular events than younger patients. This implies that CKD is not a benign condition in all elderly patients, but further investigation is required to identify those at greatest risk who may benefit from intervention. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:C269 / C276
页数:8
相关论文
共 50 条
  • [41] High Prevalence of Stage 3 Chronic Kidney Disease in Older Adults Despite Normal Serum Creatinine
    Duru, O. Kenrik
    Vargas, Roberto B.
    Kermah, Dulcie
    Nissenson, Allen R.
    Norris, Keith C.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 (01) : 86 - 92
  • [42] Validation of chronic kidney disease risk categorization system in Chinese patients with kidney disease: A cohort study
    Liu, Qingyan
    Lv, Jicheng
    Li, Haixia
    Jiao, Lili
    Yang, Hongyun
    Song, Yinan
    Xu, Guobin
    NEPHROLOGY, 2015, 20 (12) : 936 - 944
  • [43] Blood pressure modifies outcomes in patients with stage 3 to 5 chronic kidney disease
    Chiang, Heng-Pin
    Chiu, Yi-Wen
    Lee, Jia-Jung
    Hung, Chi-Chih
    Hwang, Shang-Jyh
    Chen, Hung-Chun
    KIDNEY INTERNATIONAL, 2020, 97 (02) : 402 - 413
  • [44] Prevalence and risk factors for renal artery stenosis and chronic kidney disease in Japanese patients with peripheral arterial disease
    Endo, Michiko
    Kumakura, Hisao
    Kanai, Hiroyoshi
    Araki, Yoshihiro
    Kasama, Shu
    Sumino, Hiroyuki
    Ichikawa, Shuichi
    Kurabayashi, Masahiko
    HYPERTENSION RESEARCH, 2010, 33 (09) : 911 - 915
  • [45] Association of aortic stiffness with abdominal vascular and coronary calcifications in patients with stage 3 and 4 chronic kidney disease
    Santiago, Juan Carlos Hidalgo
    Martinez, Jary Perello
    Romero, Javier Vargas
    Pallares, Jose Luis
    Dona, Alfredo Michan
    Gomez-Fernandez, Pablo
    NEFROLOGIA, 2024, 44 (02): : 256 - 267
  • [46] Hypoadiponectinemia is associated with aortic stiffness in nondialysis diabetic patients with stage 3-5 chronic kidney disease
    Lin, Ssu-Chin
    Wu, Tsung-Jui
    Wu, Du-An
    Hsu, Bang-Gee
    VASCULAR, 2022, 30 (02) : 384 - 391
  • [47] Mitigating heart failure risk in patients with diabetes and chronic kidney disease
    Kowalczyk, Nicholas S.
    Prochaska, Megan
    CURRENT OPINION IN CARDIOLOGY, 2025, 40 (03) : 178 - 183
  • [48] Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management
    Balla, Sudarshan
    Nusair, Maen B.
    Alpert, Martin A.
    CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (02) : 192 - 199
  • [49] Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides
    Vijayaraghavan, Krishnaswami
    Szerlip, Harold M.
    Ballantyne, Christie M.
    Bays, Harold E.
    Philip, Sephy
    Doyle, Ralph T., Jr.
    Juliano, Rebecca A.
    Granowitz, Craig
    POSTGRADUATE MEDICINE, 2019, : 390 - 396
  • [50] The Association between Nitric Oxide Pathway, Blood Pressure Abnormalities, and Cardiovascular Risk Profile in Pediatric Chronic Kidney Disease
    Hsu, Chien-Ning
    Lu, Pei-Chen
    Lo, Mao-Hung
    Lin, I-Chun
    Tain, You-Lin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)